Notícias Medexus Pharmaceuticals Inc - MDP | Ações Toronto Stock Exchange | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
Canadá
TSX
Medexus Pharmaceuticals Inc (MDP)
Medexus Pharmaceuticals Inc (MDP) Notícias

Medexus Pharmaceuticals Inc (MDP)

3,45

-0,01

(-0,29%)

Fechado 03 Janeiro 6:12PM

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

Medexus Pharmaceuticals Announces C$10 Million Bought-Deal Public Offering of Units

Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference

Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update

Medexus Announces New License Deal for Topical Terbinafine

Medexus Announces US$58.5 million in New Credit Facilities

Medexus to Participate in 35th Annual Roth Conference

Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022

Medexus Welcomes Two New Board Members

Medexus Secures Public Reimbursement for Cuvposa® in Quebec

Medexus Schedules Third Fiscal Quarter 2023 Conference Call

Medexus Expects Record Revenue for Fiscal Q3 2023 and Provides Business Update

Medexus Announces Strongest Quarter in Company History with Fiscal Q2 2023 Revenue of US$27.7 Million, a 55% Increase Over Fiscal Q2 2022

Medexus Schedules Second Quarter 2023 Conference Call

Medexus Announces Preliminary Revenue Results for Second Fiscal Quarter 2023

Medexus and MidCap Agree to Increase in MidCap’s Revolving Loan Commitment Amount

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Medexus Pharmaceuticals

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições